Categories
Biotech Stocks Featured Penny Stock News

Top Penny Stocks To Watch Making Headlines

Sign up for our FREE Newsletter and get:

  • The Beginner’s Handbook For Trading Penny Stocks
  • Penny Stock Alerts And Ideas
  • Learn To Trade Penny Stocks
  • Free Access to The Fastest Growing Highest Rated Trading Chatroom

Biotech penny stocks have proven to be one of the most exciting equity classes in history. Fast-growing sectors like biotechnology have experts believing that it is going to grow in the years to come. When a sector grows rapidly, then there is a definite chance of even the smaller companies recording decent growth. Even companies which have had setbacks can make a comeback.

When you talk about biotech stocks, there are likely periods of success and failure especially considering phase trials and the like. But there is a case to be made about biotech penny stocks. On that note, here is a look at 3 biotech penny stocks that should be on the watch lists of most investors.

[Read More] Are These The Best Penny Stocks To Buy In September?

Biotech Penny Stocks To Watch #1

One of the first biotech penny stocks to watch due to recent performance is Geron Corporation (GERN Stock Report). Since early August, GERN stock has climbed considerably due to the highly impressive progress of its product imetelstat. Since then the stock has performed well and gained as much as 30%. It has been one of the best performing penny stocks in the biotech space during the last 2 weeks.

However, it is not only the progress of imetelstat that is catching attention. Geron has also revealed that it has a ready pipeline of medicines that could show promise for the company as well. Due to this progress, Geron has also attracted attention from analysts. Most recently, H.C. Wainwright initiated coverage on the company with a “BUY” rating and a $4 price target.

Biotech Penny Stocks To Watch #2

Nabriva Therapeutics (NBRV Stock Report) made a major announcement this Monday that saw its stock climb as much as 32% this week so far. The company is primarily engaged in the production of anti-infective medicines. One of the most well-known products it has produced is Xenleta.

Earlier this week, Nabriva announced that the medicine has now been approved for distribution in the United States by the FDA. It goes without saying that it is a major development for a company within the biotech industry. one that could propel the company’s revenues to new heights in the coming quarters.

Biotech Penny Stocks To Watch #3

Intec Pharma (NTEC Stock Report) is the last company on this list of penny stocks. The company has seen interest building most of the week. Friday, this came to a head as NTEC stock saw its largest move and highest volume day since August 28. Though there hasn’t been any formal penny stock news, the company is likely coming off of a series of conferences.

Earlier this month, Intec revealed that it would be participating in investor conferences throughout the month of September. The most recent conference was the HC Wainwright Global Investment Conference held between September 8-10. Its next appearance will be at Ladenburg Thalmann’s Healthcare conference on the 24th.

Click To View NTEC Form 4 Filings

What may have also helped sentiment is the fact that the company’s insiders are buying stock. On August 28, it was shown that Intec Chairman, John Kozarish purchased 100,000 shares of the company at an average price of $0.459.

By J. Samuel

As a trader and expert finance writer, I enjoy finding new and emerging trends that may have been overlooked by the average masses. If there's one thing that a trader or investor wants to know, it's how to use valuable data to their advantage. My expertise is in uncovering this data and compiling it into actionable information. As a professional finance writer, I've contributed to many of the top finance platforms and pride myself on researching factual, publicly available information and using that in all of my articles.

Leave a Reply

Your email address will not be published.